Dienogest

Spezifikationen

65928-58-7CAS-Nummer

639-448-2EG-Nummer

2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrileIUPAC-Name

C20H25NO2Chemische Formel

311.4 g/molMolekulargewicht

Dienogest; 65928-58-7; Dienogestril; Dienogestum; Endometrion; STS 557; STS-557; MJR-35; 17alpha-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile; 46M3EV8HHE; ZK 37659; M 18575; M-18575; 17-alpha-Cyanomethyl-17-beta-hydroxy-estra-4,9(10)-dien-3-one; 19-Norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17alpha)-; ZK-37659; CHEBI:70708; 17-Hydroxy-3-oxo-19-nor-17alpha-pregna-4,9-diene-21-nitrile; DTXSID80891478; 19-Norpregna-4,9-diene-21-nitrile, 17-hydroxy-3-oxo-, (17-alpha)-; [(17beta)-17-hydroxy-3-oxoestra-4,9-dien-17-yl]acetonitrile; ((17beta)-17-hydroxy-3-oxoestra-4,9-dien-17-yl)acetonitrile; 17 alpha-cyanomethyl-17 beta-hydroxyestra-4,9(10)-diene-3-one; RefChem:586937; 17 alpha-cyanomethyl-17 beta-hydroxy-13 beta-methylgona-4,9-dien-3-one; G03DB08; DTXCID101030584; Dienogestrel; Dinagest; Visanne; 2-[(8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]acetonitrile; MFCD00868356; 2-((8S,13S,14S,17R)-17-hydroxy-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)acetonitrile; Dienogest [INN]; Dienogestum [Latin]; (17-hydroxy-3-oxoestra-4,9-dien-17beta-yl)acetonitrile; 17alpha-Cyanomethyl-17beta-hydroxyestra-4,9(10)-dien-3-one; BAY86-5258; UNII-46M3EV8HHE; Dienogest [USAN:INN:BAN]; Dienogest CRS; Endometrion (TN); Dienogest; Dienogestril; Dinagest; STS 557; (17alpha)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile; 17alpha-Cyanomethyl-17beta-hydroxyestra-4,9-dien-3-one; Dienogest (Standard); BAY 86-5258; DIENOGEST [JAN]; DIENOGEST [MI]; DIENOGEST [USAN]; 17-alpha-Cyanomethyl-17-beta-hydroxyestra-4,9(10)-diene-3-one; DIENOGEST [VANDF]; DIENOGEST [MART.]; 17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile; DIENOGEST [WHO-DD]; SCHEMBL37293; (17a)-17-Hydroxy-3-oxo-19-norpregna-4,9-diene-21-nitrile; Dienogest (JAN/USAN/INN); GTPL7654; STS557; DIENOGEST [ORANGE BOOK]; CHEMBL1201864; DIENOGEST [EP MONOGRAPH]; Dienogest, >=98% (HPLC); HY-B0084R; SH-T00660AA; AZFLJNIPTRTECV-FUMNGEBKSA-N; GLXC-05824; HY-B0084; MSK10876; Dienogest for system suitability CRS; EBC-07864; s1251; AKOS015840152; AKOS015896680; AC-2166; CCG-267594; CS-1782; DB09123; FH21758; NCGC00346502-04; NCGC00346502-07; 2-[(1R,3aS,3bS,11aS)-1-hydroxy-11a-methyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]acetonitrile; DA-72748; D5230; NS00000598; A10563; D03799; AB01566807_01; EN300-6477654; 17-Cyanomethyl-17-hydroxyestra-4, 9-dien-3-one; F794972; Q139160; SR-01000942230; SR-01000942230-1; BRD-K50853363-001-02-3; Dienogest, EuropePharmacopoeia (EP) Reference Standard; Z2235801839; 17-Hydroxy-3-oxo-17alpha-19-norpregna-4,9-diene-21-nitrile; Dienogest for system suitability, EuropePharmacopoeia (EP) Reference Standard; Dienogest MicronizedSynonyme